Yoga And Cardiovascular Health Trial (YACHT)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, W2 1LA
- International Centre for Circulatory Health
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 35-80 years.
- Male or female.
- European or Indian Asian descent.
- Able to understand English or Punjabi.
- Referred to a cardiac rehabilitation programme in West London post-angioplasty as treatment for an acute coronary syndrome.
Exclusion Criteria:
- Adults under 35 years or above 80 years.
- Adults aged 35-80 years who are not competent to give consent.
- Co-morbid disease or mobility limitations that would preclude participation in cardiac rehabilitation and our investigations.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Yoga 12 week programme
Usual care (standard cardiac rehabilitation programme) plus yoga intervention.
|
Those randomised to usual care plus the yoga intervention will be required to attend yoga classes twice a week for 12 weeks alongside their cardiac rehabilitation programme.
There will be 24 yoga classes in total, of which, we require the participant to attend a minimum of 18.
The yoga classes will be conducted by a teacher certified in yoga and cardiac rehabilitation and will encompass physical fitness (yoga poses), stress reduction (breath control and meditation) and positive lifestyle changes (diet, smoking and alcohol).
|
|
No Intervention: Usual care
Usual care (standard cardiac rehabilitation programme) only.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiopulmonary function
Time Frame: Week 0 (pre intervention) and week 12 (post intervention)
|
To perform a mechanistic study that determines the acute and chronic effects of yoga on cardiopulmonary function, autonomic function, blood pressure and heart rate.
|
Week 0 (pre intervention) and week 12 (post intervention)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure
Time Frame: Week 0 (pre intervention), week 1 (pre & post 1st yoga class), and week 12 (post intervention)
|
Blood pressure will be measured at baseline, at the beginning and end of the first yoga class, and immediately after the 12 week intervention.
|
Week 0 (pre intervention), week 1 (pre & post 1st yoga class), and week 12 (post intervention)
|
|
Heart rate and heart rate variability
Time Frame: Week 0 (pre intervention), week 1 (pre & post 1st yoga class), and week 12 (post intervention)
|
Heart rate and heart rate variability will be measured at baseline, at the beginning and end of the first yoga class, and immediately after the 12 week intervention.
|
Week 0 (pre intervention), week 1 (pre & post 1st yoga class), and week 12 (post intervention)
|
|
Stress hormones
Time Frame: Week 0 (pre intervention), week 1 (pre & post 1st yoga class), and week 12 (post intervention)
|
Stress hormones will be measured at baseline, at the beginning and end of the first yoga class, and immediately after the 12 week intervention.
|
Week 0 (pre intervention), week 1 (pre & post 1st yoga class), and week 12 (post intervention)
|
|
Exercise capacity
Time Frame: Week 0 (pre intervention), week 1 (pre & post 1st yoga class), and week 12 (post intervention)
|
Exercise capacity will be measured at baseline, at the beginning and end of the first yoga class, and immediately after the 12 week intervention.
|
Week 0 (pre intervention), week 1 (pre & post 1st yoga class), and week 12 (post intervention)
|
|
Body fat
Time Frame: Week 0 (pre intervention) and week 12 (post intervention)
|
Body fat will be measured at baseline and immediately after the 12 week intervention.
|
Week 0 (pre intervention) and week 12 (post intervention)
|
|
Glucose and lipids
Time Frame: Week 0 (pre intervention) and week 12 (post intervention)
|
Glucose and lipids will be measured at baseline and immediately after the 12 week intervention.
|
Week 0 (pre intervention) and week 12 (post intervention)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Nishi Chaturvedi, Imperial College London
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 12/LO/0597
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.